Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-01-02 @ 9:50 PM
Study NCT ID:
NCT02639260
Status:
COMPLETED
Last Update Posted:
2023-02-24
First Post:
2015-12-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization: